EVAS FORWARD IDE试验3年回顾分析:规范技术操作可改善结局
该研究回顾性分析EVAS FORWARD IDE试验中333例患者的1个月影像,依据近端和远端锚定区≥10 mm及最低支架距最低肾动脉≤10 mm定义技术充分,并结合修订解剖适应证分层。结果显示技术充分且解剖符合适应证者3年免于迁移、囊腔扩张和二次干预的比例最高,技术不充分与不良结局相关。
要点
- 近端和远端锚定区≥10 mm且最低支架距最低肾动脉≤10 mm为技术充分标准。
- 解剖符合适应证且技术充分者3年免于迁移率达98.6%。
- 技术不充分与囊腔扩张、迁移及二次干预风险升高相关。
核心结论
- 实现近端和远端10 mm锚定区及支架相对于肾动脉的充分定位与改善患者结局相关。
研究设计与样本
- 回顾性分析前瞻性多中心EVAS IDE试验中333例患者的1个月影像,按技术充分与否和修订解剖适应证分层比较结局。
主要发现
- 3年免于10 mm迁移率在A+/P+组为98.6%,A+/P-组为95.9%,A-/P+组为85.8%,A-/P-组为80.1%。
- 3年免于IA型内漏率在A+/P+组为98.6%,A+/P-组为100%,A-/P+组为96.4%,A-/P-组为90.3%。
- 3年免于囊腔扩张率在A+/P+组为96.9%,A+/P-组为86.0%,A-/P+组为87.1%,A-/P-组为80.5%。
- 3年免于二次干预率在A+/P+组为90.6%,A+/P-组为93.6%,A-/P+组为83.1%,A-/P-组为79.8%。
- A+/P-组报告2例术后第4天和第12天动脉瘤相关死亡,3年全因死亡和动脉瘤相关死亡在各组间相似。
关键数值与推荐
- 近端和远端锚定区≥10 mm且最低支架位于最低肾动脉10 mm以内被临床论证为技术充分的阈值。
临床怎么用
- 在Nellix EVAS操作中应争取实现近端和远端≥10 mm锚定区并将最低支架置于最低肾动脉10 mm以内以改善远期结局。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Adverse outcomes observed late in the Nellix EndoVascular Aneurysm Sealing (EVAS) System (Endologix, Inc, Irvine, Calif) investigational device exemption trial prompted refinement of the anatomic instructions for use (IFU). This study aimed to investigate the association of procedural factors during Nellix endograft deployment and patient outcomes. METHODS: We retrospectively reviewed 1-month imaging of 333 patients enrolled in the prospective, multicenter EVAS investigational device exemption trial between January 2014 and September 2016. Initial observations of those patients who met revised anatomic IFU yet still experienced late adverse events suggested that inadequate seal and low graft placement were common among these patients. Key procedural variables identified from a univariate analysis were applied to construct four cohorts stratified by procedural technical performance (technically adequate [P+] or technically inadequate [P-]) and the revised anatomic indications for use (anatomically within IFU [A+] or anatomically outside of IFU [A-]) and to compare them for aneurysm-related outcomes. A logistic regression analysis was performed to identify significant predictors of sac expansion or migration. RESULTS: Proximal and distal seal zones and low graft placement were identified by logistic regression analysis as significant predictors of sac expansion or migration. Accordingly, acquisition of ≥10-mm proximal and distal seal zones and the position of the lowest stent within 10 mm of the lowest renal artery were clinically justified as thresholds for a technically adequate procedure. Patients who did not achieve these parameters were deemed to have a technically inadequate procedure. By use of the proposed procedural adequacy criteria and established anatomic criteria, patients were stratified into four cohorts: A+/P+ (n = 77), A+/P- (n = 54), A-/P+ (n = 71), and A-/P- (n = 131). Three-year estimates of freedom from migration of 10 mm were 98.6% in A+/P+, 95.9% in A+/P-, 85.8% in A-/P+, and 80.1% in A-/P-; freedom from type IA endoleak estimates were 98.6% in A+/P+, 100% in A+/P-, 96.4% in A-/ P+, and 90.3% in A-/P- cohorts. Freedom from sac expansion and secondary intervention were 96.9% and 90.6% in A+/P+, 86.0% and 93.6% in A+/P-, 87.1% and 83.1% in A-/P+, and 80.5% and 79.8% in A-/P- groups, respectively. Two early deaths (aneurysm-related mortality) on days 4 and 12 postoperatively were reported within the A+/P- group. Kaplan-Meier estimates of freedom from all-cause mortality and aneurysm-related mortality at 3 years were similar between cohorts. CONCLUSIONS: This post hoc analysis suggests that achieving a 10-mm proximal and distal seal with adequate positioning of the endograft with respect to the renal arteries is associated with improved patient outcomes.
引用
- Carpenter JP, Lane JS, Trani J, et al. Proper technical procedures improved outcomes in a retrospective analysis of EVAS FORWARD IDE trial 3-year results. J Vasc Surg. 2020. PMID: 32035772. doi:10.1016/j.jvs.2019.11.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。